According to reports from Yahoo Finance and The Motley Fool , these were the standout performers:

: Stock price quadrupled (over 300% gain) following its expansion into CBD products and strategic supply deals. Biopharmaceutical & Industrial Stocks to Watch

: Rallied 344% over the year, driven by a move to the larger TSX exchange and international supply agreements in Germany. Aphria : Gained 292% as a major Canadian medical producer.

For investors looking at the hemp and cannabis sector in 2017, the most significant gains were concentrated among major Canadian growers and biopharmaceutical firms following pivotal partnerships and regulatory shifts. Top Performing Stocks of 2017